Aller au contenu principal
Profil bibliographique

Ziad Affas

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

11Publications signalées
40Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Acute Myocardial Infarction ResearchCardiac, Anesthesia and Surgical OutcomesAtrial Fibrillation Management and OutcomesCOVID-19 and healthcare impactsCardiac tumors and thrombi

Les publications récentes

Accès ouvert 2026 article OpenAlex

Loeffler's Endomyocarditis With Embolic Stroke Secondary to Chronic Eosinophilic Leukemia With Therapy-Related Molecular Features

Sushmithaa Ramesh, Nadia Yousif, Ziad Affas, John Bajouka et autres

BACKGROUND: Loeffler's endomyocarditis is a severe manifestation of hypereosinophilia characterized by eosinophil-mediated myocardial injury, mural thrombus formation, and endomyocardial fibrosis. While often idiopathic, it may arise from clonal eosinophilic disorders carrying higher risk of end-organ damage. CASE SUMMARY: /L) with cytopenias prompted …

us (code pays fourni par la source)

0 citations JACC Case Reports
Accès ouvert 2026 article OpenAlex

Quadrivalvular Enterococcus faecalis Infective Endocarditis in a Patient With Complex Comorbidities

John Bajouka, C Matti, Ghaid Touza, Ziad Affas et autres

BACKGROUND: Panvalvular infective endocarditis (IE) involving all 4 cardiac valves is extremely rare, with a high mortality. Management is complex when surgical intervention is precluded by severe comorbidities. CASE SUMMARY: An 81-year-old woman with end-stage renal disease and metastatic bronchial carcinoma presented …

us (code pays fourni par la source)

0 citations JACC Case Reports
Accès ouvert 2026 article OpenAlex

Percutaneous Retrieval Strategies Following Left Atrial Appendage Occluder and Peri-Device Leak Closure Embolization

Wadie David, Ziad Affas, John Bajouka, Keyshla Pagán Morales et autres

BACKGROUND: Percutaneous LAAO is an established stroke-prevention strategy in atrial fibrillation patients unsuitable for long-term anticoagulation. Device embolization is uncommon but can cause severe complications requiring urgent intervention. ABSTRACT OF THE CASE: We report 2 related cases of device embolization associated with …

us (code pays fourni par la source)

0 citations JACC Case Reports
Accès ouvert 2025 review OpenAlex

Prophylactic Beta-Blocker Therapy in Patients Who Underwent Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis

Ziad Affas, Keyur Patel, Omr R Abuzahrieh, Saman Al Barznji et autres

The role of prophylactic beta-blocker therapy in patients treated with primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) who have mildly reduced or preserved left ventricular ejection fraction (LVEF) remains a subject of debate. This systematic review and meta-analysis aimed …

us, iq (code pays fourni par la source)

0 citations Cureus
Accès ouvert 2025 article OpenAlex

Health Care Resource Utilization for Patients With Suspected Myocardial Infarction

Joseph M. Miller, Bernard Cook, Satheesh Gunaga, Raef Fadel et autres

Importance: Evaluation for myocardial infarction (MI) in emergency departments (EDs) is a common, resource-intensive process. High-sensitivity cardiac troponin I (hs-cTnI) assays have become a key tool in rapidly ruling out MI, with the potential to reduce health care resource utilization. Objective: To …

us, gb (code pays fourni par la source)

5 citations JAMA Network Open
Accès ouvert 2024 article OpenAlex

Rapid Acute Coronary Syndrome Evaluation Over One Hour With High-Sensitivity Cardiac Troponin I: A United States-Based Stepped-Wedge, Randomized Trial

Joseph Miller, Bernard Cook, Chaun M. Gandolfo, Nicholas L. Mills et autres

STUDY OBJECTIVE: The real-world effectiveness and safety of a 0/1-hour accelerated protocol using high-sensitivity cardiac troponin (hs-cTn) to exclude myocardial infarction (MI) compared to routine care in the United States is uncertain. The objective was to compare a 0/1-hour accelerated protocol for …

us, gb (code pays fourni par la source)

13 citations Annals of Emergency Medicine
2024 conference-abstract OpenAlex

Abstract P155: Identifying Inpatient and Outpatient Factors That Reduce Heart Failure Exacerbation Readmissions

Sumeet Aujla, Kutiba Tabbaa, Ziad Affas, Samer Dubaisi et autres

Acute heart failure 30-day readmissions are associated with increased patient morbidity and mortality. Our aim is to identify systemic factors that can reduce heart failure readmissions, including the implementation of a heart failure care coordination team. We assessed the hypothesis that individualized …

us (code pays fourni par la source)

0 citations Circulation
2022 book-chapter OpenAlex

Mavacamten a Novel DiseaseSpecific Treatment for Hypertrophic Obstructive Cardiomyopathy: A Meta-Analysis and Systematic Review

Ziad Affas, Ghaid Touza, Rowaid Touza, Saif Affas et autres

The purpose of this study was to conduct a systematic evaluation and outcome assessment of published and on-going studies of mavacamten therapy to treat Hypertrophic cardiomyopathy (HCM). HCM is a common genetically based cardiac disease with an estimated prevalence of 1 in …

us (code pays fourni par la source)

1 citation Book Publisher International (a part of SCIENCEDOMAIN International)
Accès ouvert 2022 review OpenAlex

Continuous positive airway pressure reduces the incidence of atrial fibrillation in patients with obstructive sleep apnea: A Meta-Analysis and Systematic Review

Ziad Affas, Saif Affas, Kutiba Tabbaa

INTRODUCTION: Obstructive sleep apnea (OSA) and atrial fibrillation (AF) are disorders that have increased in the United States during recent years. Earlier investigations have shown that underlying undiagnosed and unmanaged OSA plays a significant role in high rates and also as a …

us (code pays fourni par la source)

21 citations Spartan Medical Research Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.